Status:
UNKNOWN
Bowen Therapy for Chronic Non-specific Low Back Pain
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
United Christian Hospital
Conditions:
Pain, Back
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
There is emerging evidence that Bowen Therapy may improve musculoskeletal pain. While it can be an effective treatment strategy to enhance pain modulation; studies on the clinical effect are scarce. T...
Detailed Description
Low back pain (LBP) is one of the most common condition resulting in socioeconomic burden on health care systems. LBP is defined as pain, muscle tension, or stiffness in the area between the lower pos...
Eligibility Criteria
Inclusion
- ages between 18 and 65 years
- a diagnosis of low back pain with onset \> 12 weeks based on the evaluation by physician
- average pain intensity score of ≥ 3 on NPRS.
Exclusion
- they have acute disc prolapse or protusion with neurological sign and symptoms in the past 3-months;
- bacterial spondylitis;
- Rheumatoid arthritis;
- ankylosing spondylitis;
- back pain secondary to bone malignancy
- spinal fracture;
- osteoporotic collapse;
- cauda equina compression
- prior spinal surgery;
- psychiatric disorder (e.g. psychosis / delusion);
- current pregnancy
- previous experience with Bowen therapy.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04861129
Start Date
April 19 2021
End Date
June 30 2022
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United Christian Hospital
Kwun Tong, Hong Kong